ArticleFrontiers in oncology2022

Day +60 WT1 assessment on CD34 selected bone marrow better predicts relapse and mortality after allogeneic stem cell transplantation in acute myeloid leukemia patients.

Patrizia Chiusolo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.